CCN6/WISP3 suppresses metaplastic breast carcinoma by antagonizing a WNT/b-catenin/EZH2 cascade [ChIP-seq]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 16 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 16 samples: 16 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE250574_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1054561 and SRA study SRP479043. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 16 sample titles: 16 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7981884 PPGS_4_IgG
- GSM7981885 dnTCF4_3_IgG
- GSM7981886 PPGS_1_IgG
- GSM7981887 PPGS_2_IgG
- GSM7981888 dnTCF4_1_H3K27me3
- GSM7981889 PPGS_3_H3K27me3
- GSM7981890 dnTCF4_1_IgG
- GSM7981891 PPGS_3_IgG
- GSM7981892 dnTCF4_4_IgG
- GSM7981893 dnTCF4_2_IgG
- GSM7981894 PPGS_4_H3K27me3
- GSM7981895 dnTCF4_3_H3K27me3
- GSM7981896 dnTCF4_4_H3K27me3
- GSM7981897 dnTCF4_2_H3K27me3
- GSM7981898 PPGS_1_H3K27me3
- GSM7981899 PPGS_2_H3K27me3
- GSE250575 CCN6/WISP3 suppresses metaplastic breast carcinoma by antagonizing a WNT/b-catenin/EZH2 cascade 28 samples shares wisp3, ccn6, ezh2, wnt, antagonizing, metaplastic, suppresses, b-catenin
- GSE250538 CCN6/WISP3 suppresses metaplastic breast carcinoma by antagonizing a WNT/b-catenin/EZH2 cascade [RNA-seq] 12 samples shares wisp3, ccn6, ezh2, wnt, antagonizing, metaplastic, suppresses, b-catenin
- GSE297048 EZH2 alters aggressive variant prostate cancer subtype evolution, but is not required for neuroendocrine prostate cancer [ChIP-seq] 40 samples shares ezh2
- GSE262919 EZH2 deletion does not impact acinar cell regeneration but restricts progression to pancreatic cancer in mice [ChIP-seq] 36 samples shares ezh2
- GSE261181 Regulation of heterochromatin formation and tumor suppression in leukemia by IKAROS, HDAC1 and EZH2 [ChIP-seq] 28 samples shares ezh2
- GSE278313 Cryptic splice sites generate heterogeneous EZH2 isoforms with distinct functions in embryonic development [CUT&Tag] 20 samples shares ezh2
- GSE286459 The conserved N-terminal SANT1-binding domain (SBD) of EZH2 Regulates PRC2 Activity [delSBD-ChIP-Rx] 18 samples shares ezh2
- GSE303502 EZH2 directs breast cancer progression through the modulation of epithelial cellular plasticity [ChIP-Seq] 16 samples shares ezh2
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.